These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 1970265)

  • 21. Effects of long-term oral carvedilol on the steady-state pharmacokinetics of oral digoxin in patients with mild to moderate hypertension.
    Wermeling DP; Field CJ; Smith DA; Chandler MH; Clifton GD; Boyle DA
    Pharmacotherapy; 1994; 14(5):600-6. PubMed ID: 7997394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carvedilol increases ciclosporin bioavailability by inhibiting P-glycoprotein-mediated transport.
    Amioka K; Kuzuya T; Kushihara H; Ejiri M; Nitta A; Nabeshima T
    J Pharm Pharmacol; 2007 Oct; 59(10):1383-7. PubMed ID: 17910813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
    Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should pharmacotherapy of digoxin be reviewed in male patients with heart failure in the case of association with carvedilol?
    Souza FC; Neri JS; Marques EB; Barros RB; Scaramello CB
    Int J Cardiol; 2015 Jul; 191():4-6. PubMed ID: 25957928
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Plasma-digoxin concentrations after an intravenous loading dose.
    Bertler A; Bergdahl B; Karlsson E
    Lancet; 1974 Oct; 2(7886):958. PubMed ID: 4138368
    [No Abstract]   [Full Text] [Related]  

  • 27. Generalization of distribution--free confidence intervals for bioavailability ratios.
    Steinijans VW; Diletti E
    Eur J Clin Pharmacol; 1985; 28(1):85-8. PubMed ID: 3987790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple BASIC program for the calculation of nonparametric confidence intervals in bioequivalence testing.
    Meineke I
    Comput Methods Programs Biomed; 1987 Feb; 24(1):65-71. PubMed ID: 3829651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacology of carvedilol in normal volunteers.
    Cubeddu LX; Fuenmayor N; Varin F; Villagra VG; Colindres RE; Powell JR
    Clin Pharmacol Ther; 1987 Jan; 41(1):31-44. PubMed ID: 3802704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic interactions with digoxin.
    Rodin SM; Johnson BF
    Clin Pharmacokinet; 1988 Oct; 15(4):227-44. PubMed ID: 3056649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties.
    Sponer G; Bartsch W; Strein K; Müller-Beckmann B; Böhm E
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):317-27. PubMed ID: 2437399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of carvedilol.
    Dulin B; Abraham WT
    Am J Cardiol; 2004 May; 93(9A):3B-6B. PubMed ID: 15144929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digoxin-macrolide drug interaction.
    Bizjak ED; Mauro VF
    Ann Pharmacother; 1997 Sep; 31(9):1077-9. PubMed ID: 9296249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvedilol increases the systemic bioavailability of oral digoxin.
    De Mey C; Brendel E; Enterling D
    Br J Clin Pharmacol; 1990 Apr; 29(4):486-90. PubMed ID: 1970265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carvedilol [Coreg].
    Kukin M
    Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.